News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Prophylactic G-CSF averts febrile neutropaenia in docetaxel-treated breast cancer patients
14 Dec 2022
Prophylactic granulocyte-colony stimulating factor (G-CSF) results in a significant decrease both in the rate of febrile neutropaenia (FN) and duration of hospitalization for FN in breast cancer patients treated with docetaxel-based chemotherapy regimens (DBRs), according to a recent study.
14 Dec 2022







